Autorenfreundlich Bücher kaufen?!
Beschreibung
Doxorubicin is regarded as the most therapeutic active agent available for triple-negative breast cancer (TNBC) treatment. However, the development of drug resistance and toxicity limits its effectiveness. Thus, developing novel strategies for TNBC treatment remains a significant challenge and doxorubicin-based combinations either by metal complexes (Copper I nicotinate complex) or with autophagy modulators could provide novel strategies and alternative strategies contributed to cancer cell death pathways, autophagy and apoptosis.
Details
| Verlag | LAP LAMBERT Academic Publishing |
| Ersterscheinung | 25. Januar 2019 |
| Maße | 22 cm x 15 cm x 0.9 cm |
| Gewicht | 203 Gramm |
| Format | Softcover |
| ISBN-13 | 9786139444953 |
| Seiten | 124 |
Schlagwörter
Bekannt durch
